Ilya E. Loyko
Ilya E. Loyko has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Nidal Salim (Islim)
European Medical Center
2 shared publications - Alexander V. Stolbovoy
European Medical Center
1 shared publication - Darya P. Zvereva
European Medical Center
1 shared publication - Elina R. Moskalets
European Medical Center
1 shared publication - Kristina Tumanova
European Medical Center
1 shared publication - P. V. Koposov
European Medical Center
1 shared publication
Latest Publications
- 19 June 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 81 (2) , 116-126
Personalised radiation therapy of cervical cancer
The article deals certain necessity and contemporary possibility of method of radiotherapy (RT) component in the treatment of cervical cancer (CC) which is alternative to traditional recommendations. RT of CC accordingly to main manuals begins from external beam irradiation (EBRT) and next intracavitary/interstitial brachytherapy (BT). We see this program stand stock-still during a century, despite it not rarely possible to realize oncologic problems in the care of patients. The article contains historic analysis and arguments, that advanced contemporary EBRT may be successful alternative treatment in definite part of the patients. Traditional approach doesn’t disclaim, but here are consider the situations in the article, where new personalized care is more justify. The information was searched using our key words in the bases Rosoncoweb and PubMed, in which articles selected as possible as no more five-years old, but the earliest classic publications also used. There was done retrospective search of the information according our topic from our days to the origin of treatment method of CC in the articles else. We studied Russian and international documents about methods of RT in CC. Before to send the article in the journal we searched publications according to our theme in leading Russian and foreign radiotherapy and oncology journals.
- 19 June 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 81 (2) , 116-126
Personalised radiation therapy of cervical cancer
The article deals certain necessity and contemporary possibility of method of radiotherapy (RT) component in the treatment of cervical cancer (CC) which is alternative to traditional recommendations. RT of CC accordingly to main manuals begins from external beam irradiation (EBRT) and next intracavitary/interstitial brachytherapy (BT). We see this program stand stock-still during a century, despite it not rarely possible to realize oncologic problems in the care of patients. The article contains historic analysis and arguments, that advanced contemporary EBRT may be successful alternative treatment in definite part of the patients. Traditional approach doesn’t disclaim, but here are consider the situations in the article, where new personalized care is more justify. The information was searched using our key words in the bases Rosoncoweb and PubMed, in which articles selected as possible as no more five-years old, but the earliest classic publications also used. There was done retrospective search of the information according our topic from our days to the origin of treatment method of CC in the articles else. We studied Russian and international documents about methods of RT in CC. Before to send the article in the journal we searched publications according to our theme in leading Russian and foreign radiotherapy and oncology journals.
- Open Access
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 84-88
Efficacy of camrelizumab in combination with capecitabine and stereotactic radiation therapy in oligoprogressing squamous cell carcinomas
Camrelizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1) which demonstrated clinical efficacy in esophageal squamous cell carcinoma including in combination with 1st line chemotherapy cases of advanced disease. The article describes a clinical case of administration of camrelizumab + capecitabin in combination with local ablative intervention in the form of stereotactic radiation therapy for treatment of oligoprogressing esophageal squamous cell carcinoma. This observation shows clinical advisability of continuing immunomodulating therapy in cases of limited tumor progression with simultaneous local control of the lesions with the highest biological activity.
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 84-88
Open AccessEfficacy of camrelizumab in combination with capecitabine and stereotactic radiation therapy in oligoprogressing squamous cell carcinomas
Camrelizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1) which demonstrated clinical efficacy in esophageal squamous cell carcinoma including in combination with 1st line chemotherapy cases of advanced disease. The article describes a clinical case of administration of camrelizumab + capecitabin in combination with local ablative intervention in the form of stereotactic radiation therapy for treatment of oligoprogressing esophageal squamous cell carcinoma. This observation shows clinical advisability of continuing immunomodulating therapy in cases of limited tumor progression with simultaneous local control of the lesions with the highest biological activity.